Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Frank Scott

Concepts (280)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Inflammatory Bowel Diseases
20
2023
284
7.190
Why?
Crohn Disease
13
2022
196
4.460
Why?
Infliximab
10
2022
94
1.690
Why?
Colitis, Ulcerative
6
2021
105
1.680
Why?
Intestinal Obstruction
3
2021
40
1.620
Why?
Immunosuppressive Agents
6
2020
646
1.450
Why?
Gastrointestinal Agents
3
2020
60
1.430
Why?
Gastroenterology
4
2023
159
1.390
Why?
Tissue Adhesions
3
2021
26
1.360
Why?
Adrenal Cortex Hormones
4
2022
497
1.210
Why?
Tumor Necrosis Factor-alpha
10
2023
1139
1.200
Why?
Antibodies, Monoclonal, Humanized
3
2021
663
1.090
Why?
Intestine, Small
2
2021
122
1.060
Why?
Algorithms
6
2020
1466
1.000
Why?
JC Virus
2
2015
23
0.950
Why?
Leukoencephalopathy, Progressive Multifocal
2
2015
38
0.930
Why?
Azathioprine
5
2021
49
0.870
Why?
Esophageal Neoplasms
6
2022
273
0.840
Why?
Biological Products
3
2023
166
0.840
Why?
Abdomen
2
2021
99
0.830
Why?
Abdominal Abscess
1
2022
25
0.810
Why?
Anti-Bacterial Agents
5
2018
1477
0.780
Why?
Gastrointestinal Hemorrhage
3
2023
102
0.760
Why?
Humans
75
2023
114623
0.740
Why?
Antibodies, Viral
2
2015
520
0.740
Why?
Ustekinumab
1
2020
12
0.710
Why?
Capsule Endoscopy
1
2020
17
0.710
Why?
Biomedical Research
2
2019
585
0.700
Why?
Biosimilar Pharmaceuticals
1
2020
25
0.680
Why?
Barrett Esophagus
4
2023
147
0.680
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
2
2021
373
0.650
Why?
Quality-Adjusted Life Years
5
2021
101
0.640
Why?
Mass Screening
4
2021
1004
0.620
Why?
Surgical Procedures, Operative
1
2021
207
0.620
Why?
Intestinal Fistula
1
2018
11
0.610
Why?
Drug Utilization
1
2019
167
0.600
Why?
Colonic Diseases
1
2018
25
0.600
Why?
Postoperative Complications
2
2021
2128
0.600
Why?
Health Resources
1
2019
122
0.590
Why?
Pericardium
1
2018
50
0.590
Why?
Cost-Benefit Analysis
5
2021
544
0.590
Why?
Tuberculin Test
1
2017
32
0.590
Why?
Models, Statistical
2
2019
599
0.580
Why?
Epstein-Barr Virus Infections
1
2018
72
0.580
Why?
Time-to-Treatment
2
2019
147
0.580
Why?
Biological Factors
2
2023
35
0.570
Why?
Latent Tuberculosis
1
2017
64
0.550
Why?
Colorectal Neoplasms
5
2022
615
0.550
Why?
Antibodies, Monoclonal
4
2021
1262
0.540
Why?
Retrospective Studies
21
2023
12542
0.540
Why?
Hospitalization
3
2022
1749
0.530
Why?
Male
39
2022
55554
0.500
Why?
Natalizumab
1
2015
46
0.490
Why?
Aged
26
2023
19061
0.480
Why?
Middle Aged
29
2023
26719
0.480
Why?
Mycobacterium tuberculosis
1
2017
268
0.480
Why?
Heart Diseases
1
2018
331
0.470
Why?
Adult
27
2023
30528
0.460
Why?
Models, Theoretical
1
2018
515
0.450
Why?
Colonoscopy
6
2022
204
0.440
Why?
Age Factors
4
2020
2894
0.440
Why?
Practice Patterns, Physicians'
2
2019
1177
0.440
Why?
Lymphoma
1
2014
177
0.430
Why?
Markov Chains
3
2020
114
0.420
Why?
Communicable Diseases
1
2014
129
0.410
Why?
Risk Factors
15
2022
8628
0.410
Why?
Patient Discharge
2
2023
771
0.400
Why?
Adalimumab
3
2021
44
0.400
Why?
United Kingdom
5
2021
226
0.390
Why?
Female
35
2022
59466
0.390
Why?
Professional Competence
1
2012
81
0.380
Why?
Gastroenterologists
2
2022
18
0.380
Why?
Research Design
2
2019
928
0.370
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2013
299
0.360
Why?
Carcinoma, Squamous Cell
1
2016
577
0.360
Why?
Drug Therapy, Combination
3
2020
951
0.360
Why?
Spondylitis, Ankylosing
2
2021
43
0.350
Why?
Research Personnel
1
2012
149
0.350
Why?
Cohort Studies
9
2021
4894
0.350
Why?
Gastroesophageal Reflux
2
2023
234
0.340
Why?
Proportional Hazards Models
5
2021
1075
0.340
Why?
Pediatric Obesity
1
2016
488
0.330
Why?
Urinary Bladder Neoplasms
3
2017
196
0.330
Why?
Quality of Life
2
2021
2353
0.330
Why?
Skin Neoplasms
1
2016
756
0.310
Why?
Adenoma
2
2022
189
0.300
Why?
Electronic Health Records
5
2022
800
0.300
Why?
Databases, Factual
7
2018
1124
0.290
Why?
Neoplasm Recurrence, Local
3
2017
858
0.290
Why?
Mortality
2
2020
287
0.280
Why?
Disease Management
2
2021
560
0.280
Why?
United States
12
2021
12176
0.270
Why?
Referral and Consultation
2
2023
632
0.270
Why?
Aged, 80 and over
10
2020
6344
0.260
Why?
Patient Acceptance of Health Care
2
2022
681
0.260
Why?
Population Surveillance
2
2021
392
0.260
Why?
Case-Control Studies
8
2021
3003
0.250
Why?
Gastrointestinal Microbiome
2
2022
501
0.250
Why?
Antifungal Agents
2
2016
128
0.250
Why?
Recurrence
5
2021
935
0.240
Why?
Obesity
1
2017
2507
0.240
Why?
Delivery of Health Care
2
2021
833
0.230
Why?
Adenocarcinoma
2
2021
795
0.230
Why?
Incidence
7
2021
2311
0.230
Why?
Esophageal Stenosis
2
2014
45
0.230
Why?
Colectomy
2
2021
86
0.210
Why?
Protective Factors
2
2021
87
0.210
Why?
Esophagitis, Peptic
1
2023
16
0.210
Why?
Models, Economic
2
2020
48
0.210
Why?
Treatment Outcome
8
2021
9084
0.210
Why?
Glucocorticoids
2
2018
532
0.210
Why?
Pancreatic Neoplasms
2
2021
731
0.200
Why?
Cellulitis
1
2022
45
0.200
Why?
Odds Ratio
4
2018
953
0.200
Why?
Prognosis
3
2019
3328
0.190
Why?
Necrosis
1
2022
211
0.190
Why?
Liver Transplantation
2
2021
707
0.190
Why?
Feces
2
2022
373
0.190
Why?
Logistic Models
5
2018
1840
0.190
Why?
Rectal Fistula
1
2021
21
0.190
Why?
Aftercare
1
2023
186
0.190
Why?
Gynecologic Surgical Procedures
1
2021
44
0.180
Why?
Esophagoscopy
2
2022
184
0.180
Why?
Spondylarthritis
1
2021
36
0.180
Why?
Leukocyte L1 Antigen Complex
1
2020
29
0.180
Why?
Cystectomy
2
2017
32
0.180
Why?
Utilization Review
1
2020
34
0.180
Why?
Diabetes Mellitus
2
2021
900
0.170
Why?
Digestive System Surgical Procedures
1
2021
91
0.170
Why?
Carcinoma
1
2021
198
0.170
Why?
Tryptophan
1
2021
136
0.170
Why?
Severity of Illness Index
5
2021
2537
0.170
Why?
Metagenomics
1
2021
131
0.170
Why?
Colorectal Neoplasms, Hereditary Nonpolyposis
1
2020
30
0.170
Why?
Obesity, Morbid
1
2023
197
0.170
Why?
Urologic Surgical Procedures
1
2021
94
0.170
Why?
Metabolomics
2
2022
521
0.170
Why?
Hospitals
2
2021
581
0.170
Why?
Surveys and Questionnaires
5
2021
4620
0.170
Why?
Quality Assurance, Health Care
1
2021
311
0.160
Why?
Deglutition Disorders
1
2021
118
0.160
Why?
Follow-Up Studies
3
2019
4411
0.160
Why?
Chronic Disease
2
2022
1578
0.160
Why?
Job Satisfaction
1
2021
168
0.160
Why?
Carcinoma, Pancreatic Ductal
1
2021
211
0.160
Why?
Hospitals, Veterans
1
2020
244
0.160
Why?
Diverticulum
1
2018
11
0.160
Why?
Prevalence
3
2021
2249
0.150
Why?
Hematemesis
1
2018
3
0.150
Why?
Health Care Costs
1
2021
381
0.150
Why?
Symptom Assessment
2
2017
119
0.150
Why?
Vascular Surgical Procedures
1
2021
259
0.150
Why?
Comparative Effectiveness Research
1
2019
130
0.150
Why?
Arthritis, Rheumatoid
2
2016
1002
0.150
Why?
Intestines
1
2021
326
0.150
Why?
Clostridium Infections
1
2018
56
0.150
Why?
Endoscopic Mucosal Resection
1
2017
22
0.140
Why?
Risk Assessment
3
2016
2967
0.140
Why?
Fatal Outcome
1
2018
284
0.140
Why?
Continuity of Patient Care
1
2019
253
0.140
Why?
Cystadenoma, Mucinous
1
2016
13
0.140
Why?
Colonic Polyps
1
2017
67
0.130
Why?
Neoplasms
2
2023
2097
0.130
Why?
Itraconazole
1
2016
7
0.130
Why?
Budesonide
1
2016
87
0.130
Why?
Guideline Adherence
1
2020
490
0.130
Why?
Endoscopy, Gastrointestinal
3
2023
203
0.130
Why?
Carcinoma, Intraductal, Noninfiltrating
1
2016
49
0.130
Why?
Pharmacoepidemiology
1
2015
20
0.130
Why?
Pancreatic Diseases
1
2016
64
0.130
Why?
Cysts
1
2016
93
0.130
Why?
Burnout, Professional
1
2021
322
0.130
Why?
Neoplasms, Second Primary
1
2016
92
0.120
Why?
Data Accuracy
1
2015
48
0.120
Why?
Hyperlipidemias
1
2016
121
0.120
Why?
Antirheumatic Agents
1
2018
255
0.120
Why?
Psoriasis
1
2016
74
0.120
Why?
Arthritis, Juvenile
1
2015
42
0.120
Why?
Polypharmacy
1
2015
74
0.120
Why?
Microbiota
1
2022
647
0.120
Why?
Hedgehog Proteins
1
2016
172
0.120
Why?
Renal Insufficiency, Chronic
1
2019
486
0.120
Why?
Interferon-gamma
1
2017
719
0.120
Why?
Cholesterol
1
2016
367
0.120
Why?
Young Adult
6
2019
10455
0.120
Why?
Dilatation
1
2014
60
0.110
Why?
Early Detection of Cancer
3
2022
328
0.110
Why?
Prescription Drugs
1
2015
116
0.110
Why?
Streptococcal Infections
1
2016
127
0.110
Why?
Immunologic Factors
1
2016
220
0.110
Why?
Anastomosis, Surgical
1
2014
136
0.110
Why?
Disease Progression
2
2021
2380
0.110
Why?
Virus Diseases
1
2016
194
0.110
Why?
Registries
1
2021
1767
0.110
Why?
Radiation Injuries
1
2014
128
0.110
Why?
Foreign Bodies
1
2014
96
0.110
Why?
Primary Health Care
2
2022
1512
0.110
Why?
Biomarkers
2
2020
3408
0.100
Why?
Randomized Controlled Trials as Topic
1
2018
1214
0.100
Why?
Tissue and Organ Procurement
1
2015
228
0.100
Why?
Epidemiology
1
2012
14
0.100
Why?
Endoscopy
1
2014
246
0.100
Why?
Diabetes Complications
1
2013
211
0.100
Why?
Adolescent
6
2019
17831
0.100
Why?
Age Distribution
1
2012
342
0.090
Why?
Research Support as Topic
1
2012
108
0.090
Why?
Physicians
1
2019
772
0.090
Why?
Predictive Value of Tests
1
2016
1796
0.090
Why?
Infant
4
2016
7959
0.090
Why?
Veterans
1
2021
1248
0.090
Why?
Child, Preschool
4
2016
9108
0.090
Why?
Medicare
3
2021
665
0.080
Why?
Child
4
2022
18404
0.080
Why?
Cross-Sectional Studies
2
2016
4405
0.080
Why?
Emergency Service, Hospital
1
2019
1815
0.080
Why?
Laparoscopy
1
2012
398
0.070
Why?
Neoplasm Staging
2
2022
1167
0.070
Why?
Kaplan-Meier Estimate
2
2020
811
0.070
Why?
Breast Neoplasms
1
2016
1862
0.060
Why?
Prospective Studies
3
2023
6217
0.060
Why?
Survival Analysis
2
2017
1211
0.060
Why?
Regression Analysis
2
2017
944
0.050
Why?
Time Factors
3
2019
6112
0.050
Why?
Gastrectomy
1
2023
82
0.050
Why?
Cost Savings
1
2021
74
0.050
Why?
Granzymes
1
2021
40
0.050
Why?
Documentation
1
2023
167
0.050
Why?
Training Support
1
2021
22
0.050
Why?
Salaries and Fringe Benefits
1
2021
52
0.040
Why?
Reproducibility of Results
2
2019
2762
0.040
Why?
Morbidity
1
2021
280
0.040
Why?
Perception
1
2022
311
0.040
Why?
Metabolic Networks and Pathways
1
2021
168
0.040
Why?
SEER Program
1
2020
196
0.040
Why?
Dysbiosis
1
2021
146
0.040
Why?
Medicine
1
2021
102
0.040
Why?
Disease Susceptibility
1
2021
316
0.040
Why?
Physician's Role
1
2021
197
0.040
Why?
Career Choice
1
2021
177
0.040
Why?
Age of Onset
1
2020
445
0.040
Why?
Gene Expression Regulation, Bacterial
1
2021
285
0.040
Why?
Delayed Diagnosis
1
2019
70
0.040
Why?
Decision Support Systems, Clinical
1
2021
176
0.040
Why?
Pharmacovigilance
1
2018
14
0.040
Why?
Mathematical Concepts
1
2018
24
0.040
Why?
Academic Medical Centers
1
2021
410
0.040
Why?
Margins of Excision
1
2017
29
0.040
Why?
Societies, Medical
1
2021
663
0.040
Why?
Pilot Projects
1
2022
1372
0.040
Why?
Computational Biology
1
2021
530
0.040
Why?
Prednisone
1
2018
229
0.030
Why?
Survival Rate
1
2021
1644
0.030
Why?
Mercaptopurine
1
2016
15
0.030
Why?
Hip Fractures
1
2018
75
0.030
Why?
Decision Making
1
2023
782
0.030
Why?
Etanercept
1
2016
51
0.030
Why?
Glomerular Filtration Rate
1
2019
604
0.030
Why?
Weight Loss
1
2021
641
0.030
Why?
Intestinal Mucosa
1
2021
532
0.030
Why?
Endoscopic Ultrasound-Guided Fine Needle Aspiration
1
2016
52
0.030
Why?
Streptococcus pyogenes
1
2016
30
0.030
Why?
Cause of Death
1
2018
361
0.030
Why?
Methotrexate
1
2016
226
0.030
Why?
Bias
1
2016
179
0.030
Why?
Statistics, Nonparametric
1
2015
385
0.030
Why?
Pennsylvania
1
2014
94
0.030
Why?
Gene Expression Profiling
1
2021
1518
0.030
Why?
Neoplasm Invasiveness
1
2016
442
0.030
Why?
Mental Recall
1
2015
171
0.030
Why?
Anticoagulants
1
2018
550
0.030
Why?
Computer Simulation
1
2018
872
0.030
Why?
Drug Prescriptions
1
2016
239
0.030
Why?
Waiting Lists
1
2015
211
0.030
Why?
Medicaid
1
2018
406
0.030
Why?
Practice Guidelines as Topic
1
2021
1394
0.030
Why?
T-Lymphocytes
1
2021
1736
0.030
Why?
Multivariate Analysis
1
2016
1430
0.030
Why?
Respiratory Tract Infections
1
2015
319
0.020
Why?
Sex Factors
1
2015
1715
0.020
Why?
Cardiovascular Diseases
1
2018
1727
0.020
Why?
Scott's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)